S. Torii

Safety and effectiveness of interferon β-1a intramuscular therapy: results of the postmarketing drug surveillance in Japan.

J. Kira, T. Saida, H. Makioka, 2017, Rinsho shinkeigaku = Clinical neurology.

Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.

S. Abe, H. Yamaguchi, H. Ishibashi, 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Immunohistochemical Detection of Aflatoxin in Lesions of Aflatoxin-producing Aspergillus flavus Infection.

Takeshi Mori, T. Takaku, M. Ando, 2021, Medical mycology journal.

[Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].

M. Akiyoshi, F. Hirano, E. Maki, 2002, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension

T. Kondo, I. Kawachi, K. Hiramatsu, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study

M. Mori, K. Hiramatsu, T. Ohashi, 2019, Multiple sclerosis journal - experimental, translational and clinical.

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

M. Niino, H. Ochi, K. Hiramatsu, 2018, Advances in Therapy.

[Intravenous immunoglobulin (GB-0998) for prophylaxis of recurrent acute otitis media and lower respiratory tract infection in infancy with IgG 2 deficiency].

N. Taniguchi, Y. Sakiyama, S. Matsumoto, 1998, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial

J. Kira, T. Yamamura, D. Steiner, 2016, Neurology and Therapy.

Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan

K. Yokoyama, T. Saida, H. Makioka, 2017, Neurology and Therapy.

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study

M. Mori, K. Hiramatsu, T. Ohashi, 2019, Multiple sclerosis journal - experimental, translational and clinical.